HIKAL - Hikal | Wealthrox

Hikal

HIKAL · Pharma > Pharmaceuticals & Drugs · Chairman: Jai Hiremath · MD: Jai Hiremath · Listing date: Feb. 15, 2001 · Employees: 1528 · Navi Mumbai · http://www.hikal.com

Stock Price vs Company Growth

2.4%

10.3%

7.3%

25.2%

30.3%

49.6%

2.7%

10y

7.8%

all

8.0%

🤔 How to analyze this graph?

Last Traded Price

₹ 181 2.4%

178

259

Company Overview

Sales

1,746 Cr

Growth: -8.9%

Profit after Tax

-13 Cr

Growth: -228.7%

Small Cap

2,235 Cr

P/S: 1.3x

Industry P/S: 2.2x

Fundamentals

Sales (Cr)	₹ 1,746
Growth	-8.9%
EBITDA	13.7%
P/S	1.3x
Dividend	0.3%
P/E	-171.8x
Book Value	₹ 97.3
PEG Ratio	19.8x
ROE	-1.1%
P/B	1.9x

Shareholding Pattern

Institutions

Government Pension Fund Global

2.31 %

Promoters

Kalyani Investment Company Limited

31.36 %

Shri Badrinath Investment Pvt Ltd

16.15 %

Shri Rameshwara Investment Pvt Ltd

7.96 %

Sugandha Jai Hiremath

7.84 %

Bf Investment Limited

2.65 %

Others

Si Investments And Broking Private Limited

1.62 %

Llp

0.4 %

Iepf

0.21 %

Increase Decrease No change

Company Profile Detailed

Established in 1988 Hikal is a reliable partner to companies in the Pharmaceuticals, Biotech, Agrochemicals and Specialty Chemicals industries. They provide world-class Active Ingredients, Intermediates and R&D services and solutions in a safe, secure and confidential manner. Their advanced infrastructure has been inspected and approved by globally recognized bodies such as the USFDA. Hikal is a company built on enduring relationships.

Belongs to (11 Indices) view more

Investors (65)

internat...

ritu.aru...

Followers (6)

mike2

nitin29

vishal48